Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2025-03-21 Remuneration Information
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
8.2. Remuneration_Policy_2025_FR.pdf
Remuneration Information Classification · 98% confidence The document is titled "POLITIQUE DE RÉMUNÉRATION D'UCB 2025" (UCB Remuneration Policy 2025) and explicitly discusses the philosophy and policies related to the compensation of executive committee members and non-executive directors. This content directly aligns with the definition of a Remuneration Information document, which details compensation for top executives and directors. The French term 'Politique de rémunération' translates directly to 'Remuneration Policy'. This corresponds to the definition for Code: DEF 14A (Proxy Solicitation & Information Statement, which often includes remuneration details, but given the specific focus on compensation policy, DEF 14A is the most precise fit among the options, as it covers executive compensation disclosures, even if the document is not strictly a US DEF 14A filing, it serves the same informational purpose regarding remuneration). Since the definition for DEF 14A is 'Report detailing compensation for top executives and directors', this is the best match.
2025-03-21 French
4.3. UCB_SA_Statutory Auditor Report 2024 NL.pdf
Audit Report / Information Classification · 99% confidence The document is explicitly titled "Verslag van de commissaris aan de algemene vergadering van aandeelhouders van UCB NV over de jaarrekening voor het boekjaar afgesloten op 31 december 2024" (Commissioner's Report to the General Meeting of Shareholders of UCB NV on the annual accounts for the financial year ended December 31, 2024). It contains the auditor's opinion ("Oordeel zonder voorbehoud" - Unqualified opinion) on the annual accounts, details the scope of the audit, and discusses key audit matters. This content perfectly matches the definition of an Audit Report/Information (AR), which covers standalone audit reports and applied accounting principles, distinct from the full Annual Report (10-K) itself, although it relates to the annual financial period. FY 2024
2025-03-21 Dutch
9.1 Explanatory Note on Remuneration_EN.pdf
Remuneration Information Classification · 100% confidence The document is an explanatory note detailing proposed changes to the UCB Remuneration Policy for both Non-Executive Directors and the Executive Committee. It discusses peer group selection, fee structures, and equity guidelines. This content is specifically related to executive and director compensation policies, which falls under the 'Remuneration Information' category (DEF 14A).
2025-03-21 English
7.1. ENG_Remuneration Report 2024.pdf
Remuneration Information Classification · 100% confidence The document is a detailed 'Remuneration Report' for the year 2024, which outlines executive compensation, performance criteria, bonus outcomes, and proposed changes to the remuneration policy for the upcoming AGM. In many jurisdictions, the Remuneration Report is a mandatory section of the Annual Report or a standalone document subject to shareholder advisory votes, which aligns with the 'DEF 14A' category (Remuneration Information) as defined in the instructions.
2025-03-21 English
3.1. UCB SA_Management Report Statutory Accounts 2024 EN Final.pdf
Management Reports Classification · 100% confidence The document is titled 'Annual report of the Board of Directors for the financial year ended 31 December 2024'. It contains detailed financial performance, management's discussion of results, balance sheet analysis, and proposed dividend appropriations. While it references the 'UCB Group Integrated Annual Report 2024' for certain disclosures, this specific document is the statutory management report of the parent company (UCB SA/NV) required by law. It is a comprehensive financial report covering the full fiscal year, fitting the definition of an Annual Report (10-K).
2025-03-21 English
4.1. UCB_SA_Statutory Auditor Report 2024 EN.pdf
Audit Report / Information Classification · 100% confidence The document is explicitly titled 'Statutory auditor's report' and is addressed to the general shareholders' meeting of UCB SA. It details the audit procedures, the auditor's opinion on the annual accounts for the year ended 31 December 2024, and compliance with Belgian legal and regulatory requirements. It is a standalone audit report, not the full Annual Report itself, fitting the definition for 'Audit Report / Information' (AR). FY 2024
2025-03-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.